On March 10-14, the 68^th session of the Commission on Narcotic Drugs (CND) has been held in Vienna gathering 2100 representatives from over 100 Member States to discuss international drug policy. Throughout the session, Commission deliberated on draft resolutions covering various issues, including evidence-based drug prevention, research on stimulant use disorder treatment, alternative development, strengthening the global drug control framework and addressing the environmental impact of drugs.

A total of 179 side events and 32 thematic exhibitions were held by countries and international stakeholders during the session. Among them, EU-funded Central Asia Drug Action Programme (CADAP) supported three side events for its national partners – delegations of Kazakhstan, Kyrgyzstan and Uzbekistan.